Properties of 2 counterfactual effect definitions of a point exposure

Epidemiology

Volumn 18, Issue 4, 2007, Pages 453-460

  Flanders, W Dana ^a   Klein, Mitchel ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EXPOSURE; FOLLOW UP; METHODOLOGY; POPULATION; PRIORITY JOURNAL; SURVIVAL;

AGE FACTORS; CAUSALITY; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGIC RESEARCH DESIGN; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SURVIVAL; SYSTOLE;

EID: 34250766845     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000261472.07150.4f     Document Type: Article

References (38)

1. Rothman KJ, Greenland S, eds. Modern Epidemiology. Philadelphia, PA: Lippincott; 1998.
2. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons; 1980.
3. Prentice RL, Langer R, Stefanick ML, et al. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observation studies and the Women's Health Initiative Clinical Trial. Am J Epidemiol. 2005;162:404-414.
4. Prentice RL, Langer RD, Stefanick ML, et al. Combined analysis of women's health initiative observational and clinical trial data on post-menopausal hormone treatment and cardiovascular disease. Am J Epidemiol. 2006;163:589-599.
5. Greenland S. Absence of confounding does not correspond to collapsibility of the rate ratio or rate difference. Epidemiology. 1996;114:498-501.
6. Hernán MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15:615-625.
7. Manton Poss SS, Wing S. The black/white mortality crossover by a model of mortality selection. Human Biol. 1979;19:291-300.
8. Manton KG, Stallard E. Methods for evaluating the heterogeneity of aging processes in human populations using vital statistics data: explaining the black-white mortality crossover by a model of mortality selection. Human Biol. 1981;47-67.
9. Aalen O. Heterogeneity in survival analysis. Stat Med. 1988;7:1121-1137.
10. Vaupel JW, Yashin AI. Heterogeneity's ruses: some surprising effects of selection on population dynamics. Am Stat. 1985;39:176-185.
11. Robins JM, Greenland S. The probability of causation under a stochastic model for individual risk. Biometrics. 1989;45:1125-1138.
12. Robins JM, Greenland S. Estimability and estimation of excess and etiologic fractions. Stat Med. 1989;8:845-859.
13. Robins JM. Should compensation schemes be based on the probability of causation or expected years of life lost. J Law Policy. 2004;12:537-548.
14. Maldonado G, Greenland S. Estimating causal effects. Int J Epidemiol. 2002;31:422-429.
15. Greenland S, Robins JM. Identifiability, exchangeability, and epidemiological confounding. Int J Epidemiol. 1986;15:413-419.
16. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. New Engl J Med. 2003;349:523-534.
17. Robins JM. An analytic method for randomized trials with informative censoring: Pt 1. Lifetime Data Anal. 1995;1:241-254.
18. Grodstein F, Manson JE, Stampfer MJ. Postmenopausal hormone use and secondary prevention of coronary events in the Nurse's Health Study. Ann Int Med. 2000;135:1-8.
19. Lubin JH. Case-control methods in the presence of multiple failure times and competing risks. Biometrics. 1985;41:49-54.
20. Greenland S. Quantifying biases in causal models: classical confounding vs collider-stratification bias. Epidemiology. 2003;14:300-306.
21. Greenland S. Discussion on Statistical issues in the women's health initiative. Biometrics. 2005;61:920-921.
22. Hernán MA, Robins JM, Rodriguez LAG. Discussion on statistical issues in the women's health initiative. Biometrics. 2005;61:922-920.
23. Rothman KJ. Epidemiology. New York: Oxford University Press; 2002.
24. Robins J, Greenland S. Comment on causal inference without counter-factuals. J Am Stat Assoc. 2000;95:477-482.
25. Pearl J. Causality. New York: Cambridge University Press; 2000.
26. Dawid J. Causal inference without counterfactuals. J Am Stat Assoc. 2000;95:407-424.
27. Greenland S, Brumback B. An overview of relations among causal modeling methods. Int J Epidemiol. 2002;312:1030-1037.
28. Rubin DB. Comment: Neyman. (1923) and causal inference in experiments and observational studies. Stat Sci. 1990;5:472-480.
29. Hernán MA, Cole SR, Margolick J, et al. Structural accelerated failure time models for survival analysis in studies with time-varying treatments. Pharmacoepidemiol Drug Saf. 2005;14:477-491.
30. Stevens J, Cai J, Pamuk ER, et al. The effect of age on the association between body-mass index and mortality. New Engl J Med. 1998;338:1-7.
31. Thun M, Myers DG, Day-Lally C, et.al. Age and the exposure-response relationships between cigarette smoking and premature death in cancer prevention study II. In: Changes in Cigarette-Related Disease Risks and Their Implication for Prevention and Control. NIH; 1997: 383-413. Monograph No 97-4213.
32. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
33. Robins JM, Greenland S. Identifiability and exchangeability for direct and indirect effects. Epidemiology. 1992;3:143-155.
34. Robins JM. Causal Inference from complex longitudinal data. In: Latent Variable Modeling and Applications to Causality. Lecture Notes in Statistics. Vol 120. New York: Springer-Verlag; 1997:69-117.
35. Greenland S. Interpretation and choice of effect measures in epidemiologic analyses. Am J Epidemiol. 1987;125:761-768.
36. Slud E, Byar D. How dependent causes of death can make risk factors appear protective. Biometrics. 1988;44:265-269.
37. Robins JM, Hernán MA Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550-560.
38. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158:915-920.